Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 705

1.

A randomized study comparing the effect of loratadine added to montelukast with montelukast, loratadine, and beclomethasone monotherapies in patients with chronic asthma.

Lu S, Liu N, Dass SB, Reiss TF.

J Asthma. 2009 Jun;46(5):465-9. doi: 10.1080/02770900902846323.

PMID:
19544166
[PubMed - indexed for MEDLINE]
2.

Clinical studies of combination montelukast and loratadine in patients with seasonal allergic rhinitis.

Lu S, Malice MP, Dass SB, Reiss TF.

J Asthma. 2009 Nov;46(9):878-83. doi: 10.3109/02770900903104540.

PMID:
19905912
[PubMed - indexed for MEDLINE]
3.

Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group.

Malmstrom K, Rodriguez-Gomez G, Guerra J, Villaran C, Piñeiro A, Wei LX, Seidenberg BC, Reiss TF.

Ann Intern Med. 1999 Mar 16;130(6):487-95.

PMID:
10075616
[PubMed - indexed for MEDLINE]
4.

Montelukast, a leukotriene receptor antagonist, in combination with loratadine, a histamine receptor antagonist, in the treatment of chronic asthma.

Reicin A, White R, Weinstein SF, Finn AF Jr, Nguyen H, Peszek I, Geissler L, Seidenberg BC.

Arch Intern Med. 2000 Sep 11;160(16):2481-8.

PMID:
10979060
[PubMed - indexed for MEDLINE]
5.

Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older.

Williams B, Noonan G, Reiss TF, Knorr B, Guerra J, White R, Matz J.

Clin Exp Allergy. 2001 Jun;31(6):845-54.

PMID:
11422148
[PubMed - indexed for MEDLINE]
6.

Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group.

Reiss TF, Chervinsky P, Dockhorn RJ, Shingo S, Seidenberg B, Edwards TB.

Arch Intern Med. 1998 Jun 8;158(11):1213-20.

PMID:
9625400
[PubMed - indexed for MEDLINE]
7.

Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall.

Nayak AS, Philip G, Lu S, Malice MP, Reiss TF; Montelukast Fall Rhinitis Investigator Group.

Ann Allergy Asthma Immunol. 2002 Jun;88(6):592-600.

PMID:
12086367
[PubMed - indexed for MEDLINE]
8.

Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.

Knorr B, Franchi LM, Bisgaard H, Vermeulen JH, LeSouef P, Santanello N, Michele TM, Reiss TF, Nguyen HH, Bratton DL.

Pediatrics. 2001 Sep;108(3):E48.

PMID:
11533366
[PubMed - indexed for MEDLINE]
9.

The efficacy of montelukast during the allergy season in pediatric patients with persistent asthma and seasonal aeroallergen sensitivity.

Papadopoulos NG, Philip G, Giezek H, Watkins M, Smugar SS, Polos PG.

J Asthma. 2009 May;46(4):413-20. doi: 10.1080/02770900902847727. Erratum in: J Asthma. 2009 Oct;46(8):858.

PMID:
19484680
[PubMed - indexed for MEDLINE]
10.

Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.

Moinuddin R, deTineo M, Maleckar B, Naclerio RM, Baroody FM.

Ann Allergy Asthma Immunol. 2004 Jan;92(1):73-9.

PMID:
14756468
[PubMed - indexed for MEDLINE]
11.

Oral montelukast versus inhaled beclomethasone in 6- to 11-year-old children with asthma: results of an open-label extension study evaluating long-term safety, satisfaction, and adherence with therapy.

Maspero JF, Dueñas-Meza E, Volovitz B, Pinacho Daza C, Kosa L, Vrijens F, Leff JA.

Curr Med Res Opin. 2001;17(2):96-104.

PMID:
11759189
[PubMed - indexed for MEDLINE]
12.

Effects of montelukast and beclomethasone on airway function and asthma control.

Israel E, Chervinsky PS, Friedman B, Van Bavel J, Skalky CS, Ghannam AF, Bird SR, Edelman JM.

J Allergy Clin Immunol. 2002 Dec;110(6):847-54.

PMID:
12464949
[PubMed - indexed for MEDLINE]
13.

Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, crossover study in asthmatic patients.

Dockhorn RJ, Baumgartner RA, Leff JA, Noonan M, Vandormael K, Stricker W, Weinland DE, Reiss TF.

Thorax. 2000 Apr;55(4):260-5.

PMID:
10722763
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial.

Meltzer EO, Malmstrom K, Lu S, Prenner BM, Wei LX, Weinstein SF, Wolfe JD, Reiss TF.

J Allergy Clin Immunol. 2000 May;105(5):917-22.

PMID:
10808172
[PubMed - indexed for MEDLINE]
15.

Montelukast: a review of its therapeutic potential in persistent asthma.

Jarvis B, Markham A.

Drugs. 2000 Apr;59(4):891-928. Review.

PMID:
10804041
[PubMed - indexed for MEDLINE]
16.

Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group.

Laviolette M, Malmstrom K, Lu S, Chervinsky P, Pujet JC, Peszek I, Zhang J, Reiss TF.

Am J Respir Crit Care Med. 1999 Dec;160(6):1862-8.

PMID:
10588598
[PubMed - indexed for MEDLINE]
17.

Effects of montelukast (MK-0476), a new potent cysteinyl leukotriene (LTD4) receptor antagonist, in patients with chronic asthma.

Reiss TF, Altman LC, Chervinsky P, Bewtra A, Stricker WE, Noonan GP, Kundu S, Zhang J.

J Allergy Clin Immunol. 1996 Sep;98(3):528-34.

PMID:
8828530
[PubMed - indexed for MEDLINE]
18.

Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.

Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S.

Clin Ther. 2008 Aug;30(8):1492-504. doi: 10.1016/j.clinthera.2008.07.018.

PMID:
18803991
[PubMed - indexed for MEDLINE]
19.

Effect of montelukast, a once-daily leukotriene receptor antagonist, on peak expiratory flow variability.

Zhang J, Yu C, Noonan G, Reiss TF.

Clin Ther. 2002 Apr;24(4):574-82.

PMID:
12017402
[PubMed - indexed for MEDLINE]
20.

Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone.

Baumgartner RA, Martinez G, Edelman JM, Rodriguez Gomez GG, Bernstein M, Bird S, Angner R, Polis A, Dass SB, Lu S, Reiss TF; Montelukast Asthma Study Group.

Eur Respir J. 2003 Jan;21(1):123-8.

PMID:
12570120
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk